About Myomo
Myomo is a company based in Boston (United States) founded in 2004. Myomo has raised $17.21 million across 12 funding rounds from investors including Children's Hospital of Philadelphia, Chicago Venture Partners and Empery Asset Management. The company has 185 employees as of December 31, 2024. Myomo operates in a competitive market with competitors including Ekso Bionics, Wandercraft, SuitX, Kinova and BioLiberty, among others.
- Headquarter Boston, United States
- Employees 185 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Myomo Inc.
-
Annual Revenue
$32.55 M (USD)69.17as on Dec 31, 2024
-
Net Profit
-$6.18 M (USD)24.1as on Dec 31, 2024
-
EBITDA
-$5.43 M (USD)29.61as on Dec 31, 2024
-
Total Equity Funding
$17.21 M (USD)
in 12 rounds
-
Latest Funding Round
$3 M (USD), Debt – Conventional
Oct 23, 2019
-
Investors
Children's Hospital of Philadelphia
& 4 more
-
Employee Count
185
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Myomo
Myomo is a publicly listed company on the AMEX with ticker symbol MYO in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Myomo
Unlock access to complete
Unlock access to complete
Funding Insights of Myomo
Myomo has successfully raised a total of $17.21M across 12 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Myomo
Myomo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Children's Hospital of Philadelphia, Chicago Venture Partners and Empery Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward US companies.
|
Locked | Locked | Locked | |
|
Venture capital is directed toward life sciences and technology sectors.
|
Locked | Locked | Locked | |
|
Manages a hedge fund with strategies focused on event-driven investments.
|
Locked | Locked | Locked |
Investor details for Myomo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Myomo
Investment portfolio details for Myomo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Myomo
Detailed financials for Myomo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Myomo Comparisons
Peer comparison for Myomo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Myomo
Myomo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ekso Bionics, Wandercraft, SuitX, Kinova and BioLiberty, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Exoskeletons for medical rehabilitation and industrial productivity are provided.
|
|
| Locked | Locked | Locked |
Exoskeleton devices are provided for rehabilitation patients' mobility.
|
|
| Locked | Locked | Locked |
Lightweight exoskeletons are developed to assist walking for mobility-impaired users.
|
|
| Locked | Locked | Locked |
Robotic arms are developed for personal assistance and research.
|
|
| Locked | Locked | Locked |
Provides robotic assistance gloves for managing hand weakness.
|
Detailed competitors of Myomo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Myomo
Complete news archive for Myomo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myomo
Myomo was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Myomo is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Paul R Gudonis is the current CEO of Myomo.
Myomo is a funded company, having raised a total of $17.21M across 12 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Myomo is 185.
Annual revenue of Myomo is $32.55M as on Dec 31, 2024.
Myomo was founded in 2004 and is headquartered in Boston, United States. Operations are centered in the medical device sector, where myoelectric prosthetic technology is developed for powered braces, or orthotics, that assist weakened extremities. Support is offered to individuals affected by neuromuscular conditions, including stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, multiple sclerosis, and ALS.
Myomo's top competitors include Ekso Bionics, Wandercraft and Kinova.
Yes, Myomo is publicly traded on AMEX under the ticker symbol MYO.
Myomo has 5 investors. Key investors include Children's Hospital of Philadelphia, Chicago Venture Partners, Empery Asset Management, Mountain Group Partners, and National Science Foundation.
The ticker symbol of Myomo is MYO on AMEX.